The following table is for layout only
Goto Main Navigation
|
Goto Main Content
|
Goto Banner
|
Goto Logon Box
|
Goto Menu Bar
|
Goto Search Box
|
Goto Footer
Register
|
Log in
Home
|
About us
|
Contact us
|
Enquiries
Return to Listing
Data
Analytical tools
National lead areas
International work
Health topics
Publications
Events & Training
Return to Listing
Infliximab for Behcet disease
URL/File
Infliximab for Behcet disease_March09.do
c [58.5K]
-
Downloaded
14
times. Last downloaded 20 Dec 2012 16:20.
Format
MS Word Document (.doc)
Home Location
LHO
National or Regional
Regional
start of decorative frame for
Publishing
start of content for
Publication date
31 Mar 2009
Creator(s)
Camden PCT
end of content for
end of decorative frame for
start of decorative frame for
Relationships
start of content for
Is part of
Commissioning - PCT Clinical Exceptions - Immunological diseases
end of content for
end of decorative frame for
start of decorative frame for
You might also be interested in...
start of content for
Evidence for the use of infliximab in the treatment of Behcet’s disease
Adalimumab for Behcet’s disease
Infliximab for adult onset Still's disease
Infliximab maintenance therapy for refractory Crohn’s disease
8-weekly (scheduled) treatment of complex Crohn’s disease patient with Infliximab
More...
end of content for
end of decorative frame for
start of decorative frame for
Subject
start of content for
Keywords
Behcet disease
Clinical exceptions
Exceptional treatments
individual treatments
Infliximab
end of content for
end of decorative frame for
start of decorative frame for
Type and Language
Type and Language
start of content for
Type and Language
Resource Type
report
end of content for Type and Language
end of decorative frame for Type and Language
Stay in touch
Corporate
Media
Site help
Return to listing
© London Health Observatory, Stephenson House, 75 Hampstead Road, London, NW1 2PL. Tel: 020 7685 6774, Email:
lho.enquiries@lho.nhs.uk
The London Health Observatory will be part of Public Health England from 1 April 2013